FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224294110> ?p ?o ?g. }

• W4224294110 endingPage "12" @default.
• W4224294110 startingPage "11" @default.
• W4224294110 abstract "There is lack of consistent surrogate markers of kidney function to identify established disease, especially in early stages of CKD. Creatinine remains within normal levels until a significant reduction in renal function has occured. Cystatin C appears to be unaffected by muscle mass, diet, or gender. Its clearance is only by glomerular filtration. The plasma concentration is not influenced by inflammation or liver disease. It is not affected by optical interferences. Considering these benefits, it is more useful when trying to detect mild to moderate impairment of kidney function.An observational, analytical study was conducted over a duration of 18 months. The study participants were divided into 2 groups based on eGFR.67.5% patients had raised Cystatin C as compared to only 12.5% who had raised Creatinine. In our study, we found that Serum Creatinine (r=-0.85, p< 0.001) was better than Cystatin C (r=-0.55, p< 0.001) in all stages of CKD. However, in patients with eGFR ≥ 60 ml/min/m2. Cystatin C (r = -0.68, p<0.001) was a more sensitive marker to detect renal dysfunction at an early stage as compared to Serum Creatinine (r = -0.48, p<0.001). Overall, the AUC (Area Under the Curve) for Serum Creatinine is more than Cystatin C. However, in patients with eGFR≥ 60ml/ min/1.73m2, AUC for cystatin C is more. Thus, Cystatin C is more sensitive than Serum Creatinine to detect early renal dysfunction.We found out that both serum creatinine and serum cystatin C were significantly increased across CKD groups but cystatin C is a better predictor of CKD than creatinine in stages with eGFR≥60 ml/min/1.73 m2 as serum cystatin C was found to be raised contrary to serum creatinine which was within normal limits, although in stages with eGFR<60 ml/min/1.73 m2 there was no significant difference between the two. We found out that normal serum creatinine levels during the stage of kidney disease with eGFR≥60 ml/min/1.73 m2 does not necessarily mean normal renal function. Cystatin C should be encouraged as a screening tool for early renal impairment in the patient as the risk of developing CKD, especially in long-standing hypertensive and diabetic patients as an adjunct to creatinine estimation. It should also be included in the management protocol for these patients." @default.
• W4224294110 created "2022-04-26" @default.
• W4224294110 creator A5030674736 @default.
• W4224294110 creator A5042516627 @default.
• W4224294110 creator A5042965567 @default.
• W4224294110 creator A5065512323 @default.
• W4224294110 creator A5088510854 @default.
• W4224294110 date "2022-04-01" @default.
• W4224294110 modified "2023-09-29" @default.
• W4224294110 title "Study of Serum Cystatin C and Serum Creatinine in Different Stages of Chronic Kidney Disease Patients." @default.
• W4224294110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35443444" @default.
• W4224294110 hasPublicationYear "2022" @default.
• W4224294110 type Work @default.
• W4224294110 citedByCount "1" @default.
• W4224294110 countsByYear W42242941102023 @default.
• W4224294110 crossrefType "journal-article" @default.
• W4224294110 hasAuthorship W4224294110A5030674736 @default.
• W4224294110 hasAuthorship W4224294110A5042516627 @default.
• W4224294110 hasAuthorship W4224294110A5042965567 @default.
• W4224294110 hasAuthorship W4224294110A5065512323 @default.
• W4224294110 hasAuthorship W4224294110A5088510854 @default.
• W4224294110 hasConcept C126322002 @default.
• W4224294110 hasConcept C126894567 @default.
• W4224294110 hasConcept C134018914 @default.
• W4224294110 hasConcept C159641895 @default.
• W4224294110 hasConcept C2778653478 @default.
• W4224294110 hasConcept C2779548226 @default.
• W4224294110 hasConcept C2780306776 @default.
• W4224294110 hasConcept C2780412452 @default.
• W4224294110 hasConcept C71924100 @default.
• W4224294110 hasConcept C90924648 @default.
• W4224294110 hasConceptScore W4224294110C126322002 @default.
• W4224294110 hasConceptScore W4224294110C126894567 @default.
• W4224294110 hasConceptScore W4224294110C134018914 @default.
• W4224294110 hasConceptScore W4224294110C159641895 @default.
• W4224294110 hasConceptScore W4224294110C2778653478 @default.
• W4224294110 hasConceptScore W4224294110C2779548226 @default.
• W4224294110 hasConceptScore W4224294110C2780306776 @default.
• W4224294110 hasConceptScore W4224294110C2780412452 @default.
• W4224294110 hasConceptScore W4224294110C71924100 @default.
• W4224294110 hasConceptScore W4224294110C90924648 @default.
• W4224294110 hasIssue "4" @default.
• W4224294110 hasLocation W42242941101 @default.
• W4224294110 hasOpenAccess W4224294110 @default.
• W4224294110 hasPrimaryLocation W42242941101 @default.
• W4224294110 hasRelatedWork W10389330 @default.
• W4224294110 hasRelatedWork W12954717 @default.
• W4224294110 hasRelatedWork W16690676 @default.
• W4224294110 hasRelatedWork W1764159 @default.
• W4224294110 hasRelatedWork W220526 @default.
• W4224294110 hasRelatedWork W2941215 @default.
• W4224294110 hasRelatedWork W6217044 @default.
• W4224294110 hasRelatedWork W679746 @default.
• W4224294110 hasRelatedWork W8180710 @default.
• W4224294110 hasRelatedWork W9077844 @default.
• W4224294110 hasVolume "70" @default.
• W4224294110 isParatext "false" @default.
• W4224294110 isRetracted "false" @default.
• W4224294110 workType "article" @default.